Metabolism of a neurotensin (8–13) analog by intestinal and nasal enzymes, and approaches to stabilize this peptide at these absorption sites
- 4 April 1995
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 117 (1) , 95-100
- https://doi.org/10.1016/0378-5173(94)00335-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Influences of regional differences in activities of brush-border membrane peptidases within the rat intestine on site-dependent stability of peptide drugsLife Sciences, 1993
- Neurotensin receptor binding and antinociceptive activity for lipophilic Nα-amido neurotensin(9–13) analogsBioorganic & Medicinal Chemistry Letters, 1993
- Stable isosteres of neurotensin c-terminal pentapeptides derived by modification of the amide functionBioorganic & Medicinal Chemistry Letters, 1993
- Chemical and α-Chymotrypsin-Mediated Proteolytic Degradation of Insulin in Bile Salt-Unsaturated Fatty Acid Mixed Micellar SystemsPharmaceutical Research, 1993
- An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidasesLife Sciences, 1990
- Penetration and enzymatic barriers to peptide and protein absorptionAdvanced Drug Delivery Reviews, 1989
- The Use of α-Aminoboronic Acid Derivatives to Stabilize Peptide Drugs During Their Intranasal AbsorptionPharmaceutical Research, 1989
- Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: Similarities in rates and involvement of aminopeptidasesLife Sciences, 1986
- Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogsJournal of Pharmacy and Pharmacology, 1985
- Absorption of drugs from the nasal mucosa of ratInternational Journal of Pharmaceutics, 1981